Testing effectiveness (Phase 2)Study completedNCT01585207
What this trial is testing
Proof-of-Concept Safety Study of CPP-109 (Vigabatrin) for Treatment Refractory Tourette's Disorder
Who this might be right for
Tourette's Disorder
Barbara J. Coffey 4